Evaluation of Orexin‐A, Adiponectin and Apelin‐13 Serum Levels in Children Diagnosed With Attention Deficit Hyperactivity Disorder
International Journal of Developmental Neuroscience · 2025-04 · 85 (2)
DOI: 10.1002/jdn.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, online erschienen am 29.03.2025. Verfasst von Serdar Avunduk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Child and Adolescent Psychiatry, Balıkesir Atatürk City Hospital, Balıkesir, Turkey. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Intercellular Signaling Peptides and Proteins, Adiponectin, Orexins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Pamukkale University Scientific Research Projects Coordination Unit.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
This study investigates the role of orexin‐a, adiponectin (HMWA) and apelin‐13 serum levels in the etiopathogenesis of attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder with unclear aetiology involving neuropathological, genetic and environmental factors.
Methods
The study involved 37 children with ADHD and 35 healthy controls, aged 6–18 years, with no history of other physical or psychiatric illnesses and no psychotropic medication use in the last 6 months. Serum levels of orexin‐a, adiponectin (HMWA) and apelin‐13 were measured using enzyme‐linked immunosorbent assay (ELISA). ADHD symptoms were assessed through Diagnostic and Statistical Manual of Mental Disorders‐5 (DSM‐5)–based clinical interviews, Conners Parent and Teacher Rating Scales and Wisconsin Card Sorting Test.
Results
No significant differences in serum orexin‐a, adiponectin (HMWA) and apelin‐13 levels were found between the ADHD and control groups. Additionally, there was no relationship between orexin‐a, apelin‐13 and adinopectin levels and ADHD symptoms and Wisconsin Card Sorting Test results. Analysis of adiponectin levels in preadolescent children aged 6–11, adjusting for age and BMI, revealed a statistically significant reduction in the ADHD group ( p = 0.002).
Conclusion
The results did not demonstrate any correlation between ADHD and the levels of orexin‐a and apelin‐13. However, the study revealed that children with ADHD, aged 6–11, exhibited decreased adiponectin concentrations. These results suggest that a decrease in serum adinopectin levels may be associated with ADHD in children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Child and Adolescent Psychiatry, Balıkesir Atatürk City Hospital, Balıkesir, Turkey.
- Child and Adolescent Psychiatry, Pamukkale Univercity, Denizli, Turkey.
- Biochemistry, Pamukkale Univercity, Denizli, Turkey.
ORCID-Profile: Serdar Avunduk, Ömer Başay, Süleyman Demir, Ayşen Çetin Kardeşler
Förderung
- Pamukkale University Scientific Research Projects Coordination Unit
Zitieren
APA
Avunduk, S., Başay, Ö., Demir, S., & Kardeşler, A. Ç. (2025). Evaluation of Orexin‐A, Adiponectin and Apelin‐13 Serum Levels in Children Diagnosed With Attention Deficit Hyperactivity Disorder. International Journal of Developmental Neuroscience, 85(2). https://doi.org/10.1002/jdn.70014
Vancouver
Avunduk S, Başay Ö, Demir S, Kardeşler AÇ. Evaluation of Orexin‐A, Adiponectin and Apelin‐13 Serum Levels in Children Diagnosed With Attention Deficit Hyperactivity Disorder. International Journal of Developmental Neuroscience. 2025;85(2). doi:10.1002/jdn.70014
BibTeX
@article{Avunduk2025,
author = {Avunduk, Serdar and Başay, Ömer and Demir, Süleyman and Kardeşler, Ayşen Çetin},
title = {Evaluation of Orexin‐A, Adiponectin and Apelin‐13 Serum Levels in Children Diagnosed With Attention Deficit Hyperactivity Disorder},
journal = {International Journal of Developmental Neuroscience},
year = {2025},
volume = {85},
number = {2},
doi = {10.1002/jdn.70014}
}
EUVIMED